The Rise of Medical-Grade Dermatologist Skincare
The Surge in Science-Backed Skincare
The beauty industry has long been dominated by big consumer-facing brands, but a seismic shift is underway in the form of medical-grade skincare brands backed by dermatologists and powered by cutting-edge science.The global skincare market is projected to exceed $200 billion by 2030, with the medical-grade sector growing exponentially, driven by consumer demand for effective, science-backed solutions.
The rise of medical-grade skincare—a fusion of clinical efficacy and luxury—has carved out a lucrative niche within the broader beauty market. Unlike traditional consumer brands, these science-backed formulations are designed to deliver measurable results, often with the oversight of dermatologists or skincare professionals. This approach has captivated a growing base of savvy consumers, attracting significant attention from private equity (PE) and venture capital (VC) investors eager to capitalise on this booming sector.
What Defines Medical-Grade Skincare?
Although the term “medical-grade skincare” lacks formal regulation, it generally refers to products with higher concentrations of active ingredients, rigorous clinical research, and professional endorsements. Unlike over-the-counter (OTC) skincare, these products often bridge the gap between beauty and medicine, promising results that go beyond surface-level improvements.
Consumers are increasingly demanding solutions tailored to specific skin concerns, such as aging, acne, and hyperpigmentation, and they want these solutions to work—fast. This demand for visible efficacy has driven growth in the medical-grade segment, which blends the allure of luxury with the credibility of science. However, the market’s unregulated nature means that brands must rely on transparent marketing and solid clinical backing to stand out.
Private Equity and Venture Capital Enter the Scene
The rapid growth of medical-grade skincare has not gone unnoticed by investors. PE and VC firms have poured millions into promising brands, attracted by their high margins, scalable business models, and potential for global expansion. These investments are fueling innovation and helping brands scale their operations, particularly in direct-to-consumer (DTC) and omnichannel distribution.
Brands to Watch in 2025
Medik8
Medik8 is a British premium skincare brand renowned for its clinical claims and professional-grade formulations. Known for products like the Crystal Retinal range and Liquid Peptides serum, Medik8 stands out for its commitment to science and innovation. The brand produces all its products in-house at its state-of-the-art production facility and research lab in Buckinghamshire. Its global distribution network includes professional channels and specialist skincare retailers in countries like Australia, Mexico, and Ukraine, with a select presence in premium beauty retailers like Space NK in the UK. With private equity backing from Inflexion, Medik8 is well-positioned for further expansion into emerging markets and strengthening its omnichannel presence.
Dr. Barbara Sturm
Dr. Barbara Sturm’s brand is synonymous with luxury and science, offering anti-inflammatory, molecularly advanced skincare solutions. A celebrity favorite, the brand has achieved cult status while maintaining its exclusivity. In 2021, Dr. Barbara Sturm secured significant investment from a private equity firm to enhance its global operations. This investment has supported the opening of flagship stores, an expanded retail presence, and a stronger focus on wellness-oriented skincare. The brand’s blend of clinical efficacy and luxury continues to drive its appeal among discerning consumers.
Dr. Sam’s Skincare
Founded by dermatologist Dr. Sam Bunting, Dr. Sam’s Skincare offers a minimalist yet highly effective approach to skincare. Its simplified routines are designed to address common concerns like acne and sensitivity without overwhelming consumers. While investment details are less publicly available, strategic backers have supported the brand’s DTC-focused growth. Dr. Sam’s direct connection with customers and commitment to transparency position it as a standout in the medical-grade skincare space.
111SKIN
111SKIN, founded by plastic surgeon Dr. Yannis Alexandrides, is a luxury skincare brand that merges medical expertise with premium formulations. Known for its space-inspired skincare innovations, the brand has attracted a global clientele seeking cutting-edge products. Recently, 111SKIN received a significant minority investment from SKKY Partners, the private equity firm co-founded by Kim Kardashian and Jay Sammons. SKKY Partners, which invests in culturally relevant, high-growth brands, aims to help 111SKIN expand its direct-to-consumer business and strengthen its global presence. This investment comes at a time when the brand’s reputation for innovation and luxury is reaching new heights.
Augustinus Bader
Few brands have disrupted the luxury skincare market like Augustinus Bader. Developed by German stem-cell scientist Professor Augustinus Bader, the brand’s proprietary TFC8® technology has been hailed as revolutionary for skin regeneration and anti-aging. In 2022, Augustinus Bader closed a $25 million funding round led by Impala Ventures. This funding has allowed the brand to accelerate its global expansion, strengthen its DTC channels, and invest further in research and development. With its unique ability to combine advanced science with luxury, Augustinus Bader is setting a new standard in the medical-grade skincare industry.
Key Investment Trends
Investment in medical-grade skincare is driven by several key trends:
- Scalability: Brands with strong DTC models and the ability to transition seamlessly into omnichannel distribution are highly attractive to investors.
- Proprietary Technology: Innovations like TFC8® by Augustinus Bader or space-inspired formulations by 111SKIN differentiate brands in a crowded market.
- Global Expansion: Markets in Asia and the Middle East represent significant growth opportunities, as consumers in these regions increasingly prioritize luxury and efficacy in skincare.
- Loyal Customer Bases: Medical-grade brands often inspire deep loyalty among their customers, providing a stable revenue stream and reducing reliance on constant customer acquisition.
Challenges and Opportunities
While the medical-grade skincare sector is thriving, it is not without its challenges. The lack of standardisation around the term “medical-grade” can confuse consumers, and high R&D costs can be a barrier for smaller players. However, the opportunities far outweigh the challenges. Growing consumer awareness of skincare ingredients, combined with the credibility offered by dermatologist-backed brands, creates fertile ground for further growth and innovation.
Conclusion: The Future of Medical-Grade Skincare
As science-backed skincare continues to bridge the gap between medicine and beauty, brands like Medik8, Dr. Barbara Sturm, Dr. Sam’s, 111SKIN, and Augustinus Bader are leading the charge. With the support of private equity and venture capital firms, these companies are not just creating better products—they are redefining the industry. As consumer demand for effective, luxurious skincare grows, the future of medical-grade skincare looks brighter than ever.
Source:
https://www.businessoffashion.com/articles/beauty/kim-kardashians-skky-partners-takes-minority-stake-in-111skin/
https://www.businessoffashion.com/articles/beauty/top-ma-beauty-brands-2025
Meet Jessica
Jessica is an accomplished recruitment leader with over 11 years of experience in the beauty and wellness sector, specialising in hiring for leading beauty brands and fast-growing SMEs.
As Associate Director, Jessica leads the Beauty and Lifestyle division, overseeing a dedicated team of Senior Search Executives and Researchers. Together, they provide a highly personalised, hands-on approach to each recruitment project, ensuring that every client’s needs are met and hiring goals are achieved.
Jessica has a unique and in-depth understanding of the beauty industry, with a vast network spanning global markets. She advises clients on their expansion strategies across EMEA and the US, offering guidance on market entry, office locations, and building teams from the ground up.
Her recruitment expertise covers roles across Creative, Marketing, Ecommerce, Commercial, Sales, and NPD, from Senior Management to C-suite level.
